What is the primary concern associated with the NRTI class of drugs?

What is the primary concern associated with the NRTI class of drugs?

• A. Lactic acidosis
• B. Cardiovascular disease
• C. Neuropathy
• D. Bone density loss

Answer: (A)

The primary concern associated with the NRTI class of drugs is lactic acidosis. This is a significant side effect that can occur because NRTIs interfere with the normal metabolism of the cells, leading to an accumulation of lactic acid in the bloodstream. Lactic acidosis can manifest with symptoms such as nausea, abdominal pain, and rapid breathing and can become severe if not addressed promptly. NRTIs, or nucleoside reverse transcriptase inhibitors, are often used in the treatment of HIV and are known to have various side effects. While other concerns like cardiovascular disease, neuropathy, and bone density loss are associated with different classes of antiretroviral medications or specific agents, lactic acidosis remains a hallmark concern when administering NRTIs, particularly with drugs like stavudine and didanosine, which have been linked to higher incidences of this adverse effect. Understanding the risk of lactic acidosis helps healthcare providers monitor their patients effectively and informs decisions regarding the choice of antiretroviral therapy.

The primary concern associated with the NRTI class of drugs is lactic acidosis. This is a significant side effect that can occur because NRTIs interfere with the normal metabolism of the cells, leading to an accumulation of lactic acid in the bloodstream. Lactic acidosis can manifest with symptoms such as nausea, abdominal pain, and rapid breathing and can become severe if not addressed promptly.

NRTIs, or nucleoside reverse transcriptase inhibitors, are often used in the treatment of HIV and are known to have various side effects. While other concerns like cardiovascular disease, neuropathy, and bone density loss are associated with different classes of antiretroviral medications or specific agents, lactic acidosis remains a hallmark concern when administering NRTIs, particularly with drugs like stavudine and didanosine, which have been linked to higher incidences of this adverse effect.

Understanding the risk of lactic acidosis helps healthcare providers monitor their patients effectively and informs decisions regarding the choice of antiretroviral therapy.